Hyam Levitsky

Hyam Levitsky

Hoofd Techniek/Wetenschap/O&O bij CENTURY THERAPEUTICS, INC.

Vermogen: 1 M $ op 30-06-2024

66 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Dr. Hyam I.
Levitsky
, MD, is a President-Research & Development at Century Therapeutics, Inc., an Independent Director at Replimune Group, Inc., a Member at American Association for Cancer Research, a Member at American Society of Hematology and a Member-Cancer Immunotherapy Consortium at Cancer Research Institute.
He is on the Board of Directors at Replimune Group, Inc. and Prokarium Ltd.
Dr. Levitsky was previously employed as a President-Research & Development by Century Therapeutics, Inc. /Old/, a Chief Scientific Officer & Executive VP by Juno Therapeutics, Inc., a Head-Cancer Immunology Experimental Medicine by Roche Holding AG, a Head-Cancer Immunotherapy Experimental Medicine by F.
Hoffmann-La Roche Ltd., a Scientific Director by The Johns Hopkins University, a Member by American Society for Clinical Investigation, a Professor by The Johns Hopkins University School of Medicine, an Assistant Professor by The Sidney Kimmel Comprehensive Cancer Center, and a Head-Cancer Immunology by Roche Pharmaceuticals, Inc. He also served on the board at Agenus, Inc. and Carisma Therapeutics, Inc. He received his undergraduate degree from School of Engineering & Applied Science and a doctorate degree from The Johns Hopkins University School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
07-03-2024 560 544 ( 0.66% ) 1 M $ 30-06-2024
01-04-2024 0 ( -.--% ) - $ 30-06-2024

Actieve functies van Hyam Levitsky

BedrijvenFunctieBegin
REPLIMUNE GROUP, INC. Directeur/Bestuurslid 01-05-2018
CENTURY THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 11-04-2023
Directeur/Bestuurslid 01-10-2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Alle actieve functies van Hyam Levitsky

Eerdere bekende functies van Hyam Levitsky

BedrijvenFunctieEinde
CENTURY THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 01-01-2023
JUNO THERAPEUTICS INC Hoofd Techniek/Wetenschap/O&O 01-04-2018
ROCHE HOLDING AG Corporate Officer/Principal 01-02-2015
░░ ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Hyam Levitsky in detail bekijken

Opleiding van Hyam Levitsky

School of Engineering & Applied Science Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hyam Levitsky in detail bekijken

Connecties

100 +

Eerstegraads connecties

18

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
AGENUS INC.

Health Technology

REPLIMUNE GROUP, INC.

Health Technology

ROCHE HOLDING AG

Health Technology

CENTURY THERAPEUTICS, INC.

Health Technology

CARISMA THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit10

Commercial Services

Health Technology

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Hyam Levitsky